Cargando…

Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens

Rationale: Cancer phosphoproteomics can provide insights regarding kinases that can be targeted for therapeutic applications. Monitoring the phosphoproteomics in cancer is expected to play a key role in optimizing treatments with kinase inhibitors. Clinical phosphoproteomics in surgical tissues and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, Yuichi, Hirano, Hidekazu, Shoji, Hirokazu, Tada, Asa, Isoyama, Junko, Kakudo, Akemi, Gunji, Daigo, Honda, Kazufumi, Boku, Narikazu, Adachi, Jun, Tomonaga, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019165/ https://www.ncbi.nlm.nih.gov/pubmed/32089736 http://dx.doi.org/10.7150/thno.37623

Ejemplares similares

Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer
por: Hirano, Hidekazu, et al.
Publicado: (2022)

Systematic identification of ALK substrates by integrated phosphoproteome and interactome analysis
por: Adachi, Jun, et al.
Publicado: (2022)

Improved phosphoproteomic analysis for phosphosignaling and active-kinome profiling in Matrigel-embedded spheroids and patient-derived organoids
por: Abe, Yuichi, et al.
Publicado: (2018)

Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab
por: Abe, Yuichi, et al.
Publicado: (2017)

Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer
por: Kudo-Saito, Chie, et al.
Publicado: (2022)

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer
por: Oshima, Kotoe, et al.
Publicado: (2022)

Comprehensive proteomic profiling of plasma and serum phosphatidylserine-positive extracellular vesicles reveals tissue-specific proteins
por: Muraoka, Satoshi, et al.
Publicado: (2022)

Automated Proteomics Sample Preparation of Phosphatidylserine-Positive Extracellular Vesicles from Human Body Fluids
por: Muraoka, Satoshi, et al.
Publicado: (2022)

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
por: Shoji, Hirokazu, et al.
Publicado: (2021)

Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy
por: Tamura, Nobumasa, et al.
Publicado: (2020)

Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer
por: Takamizawa, Shigemasa, et al.
Publicado: (2021)

The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
por: Shoji, Hirokazu, et al.
Publicado: (2017)

Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
por: Onidani, Kaoru, et al.
Publicado: (2019)

Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer
por: Aoki, Masahiko, et al.
Publicado: (2019)

Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab
por: Kadono, Toru, et al.
Publicado: (2023)

Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study
por: Ishikawa, Masashi, et al.
Publicado: (2021)

12-Hydroxyeicosapentaenoic acid inhibits foam cell formation and ameliorates high-fat diet-induced pathology of atherosclerosis in mice
por: Nagatake, Takahiro, et al.
Publicado: (2021)

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
por: Masuda, Ken, et al.
Publicado: (2019)

Dietary Omega-3 Fatty Acid Dampens Allergic Rhinitis via Eosinophilic Production of the Anti-Allergic Lipid Mediator 15-Hydroxyeicosapentaenoic Acid in Mice
por: Sawane, Kento, et al.
Publicado: (2019)

Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report
por: Watanabe, Sho, et al.
Publicado: (2019)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

HER2-positive gastric cancer
por: Boku, Narikazu
Publicado: (2013)

Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL‐expressing plasmacytoid dendritic cells in mice
por: Hirata, So‐ichiro, et al.
Publicado: (2020)

Possible Therapeutic Strategy Involving the Purine Synthesis Pathway Regulated by ITK in Tongue Squamous Cell Carcinoma
por: Onidani, Kaoru, et al.
Publicado: (2021)

Vitamin B1 Supports the Differentiation of T Cells through TGF-β Superfamily Production in Thymic Stromal Cells
por: Hirata, So-ichiro, et al.
Publicado: (2020)

Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy
por: Tada, Kohei, et al.
Publicado: (2015)

Real‐world emetic risk of chemotherapy and the corresponding antiemetic therapy in Japan: A study based on a nationwide database
por: Okuyama, Ayako, et al.
Publicado: (2021)

A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2023)

Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology
por: Aoki, Masahiko, et al.
Publicado: (2020)

Phosphoproteomics Meets Chemical Genetics: Approaches for Global Mapping and Deciphering the Phosphoproteome
por: Jurcik, Jan, et al.
Publicado: (2020)

Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy
por: Takemoto, Shinnosuke, et al.
Publicado: (2023)

Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)
por: Iwasa, Satoru, et al.
Publicado: (2020)

Phosphoproteomics taken to heart
por: Lundby, Alicia, et al.
Publicado: (2013)

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
por: Kurokawa, Yukinori, et al.
Publicado: (2009)

Clinical and Technical Phosphoproteomic Research
por: López, Elena, et al.
Publicado: (2011)

Profiling the Trypanosoma cruzi Phosphoproteome
por: Marchini, Fabricio K., et al.
Publicado: (2011)

Enrichment techniques employed in phosphoproteomics
por: Fíla, Jan, et al.
Publicado: (2011)

Integrating phosphoproteomics in systems biology
por: Liu, Yu, et al.
Publicado: (2014)

Characterization of the Phosphoproteome in SLE Patients
por: Zhang, Xinzhou, et al.
Publicado: (2012)

Phosphoproteomics and Lung Cancer Research
por: López, Elena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6dcrb0snt5q01802hv69acm94u